๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Antineutrophil Cytoplasmic Antibody-associated Vasculitis

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases NCT06978647Phase 11 site๐Ÿ“ Beijing China Immunotech (Beijing) Biotechnology Co., Ltd. ยท Tests: YTS109 cell BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases NCT06794008Phase 21 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: BCMA-CD19 CAR-T therapy A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases NCT06980597Phase 12 sites๐Ÿ“ Beijing๐Ÿ“ Beijing Beijing GoBroad Hospital ยท Tests: OL-108 CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases NCT06941129Phase 11 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: UCAR T-cell The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome NCT07275190NA1 site๐Ÿ“ Pavia Fondazione IRCCS Policlinico San Matteo di Pavia ยท Tests: Blood draw for the laboratory assessment Vasculitis Pregnancy Registry NCT02593565n/a1 site๐Ÿ“ Tampa University of Pennsylvania ยท Tests: Online questionnaires A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO Trial NCT05946564Phase 325 sites๐Ÿ“ Amiens๐Ÿ“ Angers๐Ÿ“ Boulogne-sur-Mer Assistance Publique - Hรดpitaux de Paris ยท Tests: Pioglitazone (ACTOSยฎ), Placebo of Pioglitazone Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases. NCT06581562Phase 11 site๐Ÿ“ Plantation IRIS Research and Development, LLC ยท Tests: AB-101, Rituximab, Cyclophosphamide, Fludarabine A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases NCT07104721Phase 11 site๐Ÿ“ Hefei China Immunotech (Beijing) Biotechnology Co., Ltd. ยท Tests: YTS109 cell A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis NCT06072482Phase 483 sites๐Ÿ“ Anchorage๐Ÿ“ Scottsdale๐Ÿ“ Surprise Amgen ยท Tests: Avacopan, Placebo, Standard of Care Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases NCT07301164EARLY Phase 11 site๐Ÿ“ Beijing Peking University Third Hospital ยท Tests: BCT301 Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW) NCT06983821Phase 32 sites๐Ÿ“ Hamilton๐Ÿ“ Ottawa Ottawa Hospital Research Institute ยท Tests: Cyclophosphamide, Standard of Care (SOC), Prednisone, Rituximab (R) Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders NCT07089121Phase 1, Phase 23 sites๐Ÿ“ Washington D.C.๐Ÿ“ St Louis๐Ÿ“ Cincinnati Cartesian Therapeutics ยท Tests: Descartes-08 A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis ๏ผˆEGPA๏ผ‰ NCT05979051Phase 2, Phase 32 sites๐Ÿ“ Beijing๐Ÿ“ Hangzhou Guangdong Hengrui Pharmaceutical Co., Ltd ยท Tests: SHR-1703, Mepolizumab Injection FT839 in Autoimmune Diseases NCT07800871Phase 1, Phase 21 site๐Ÿ“ Fullerton Fate Therapeutics ยท Tests: FT839 TAVNEOS for Otolaryngologic Manifestations of Granulomatosis With Polyangiitis NCT07176546Phase 2, Phase 32 sites๐Ÿ“ Edison๐Ÿ“ New York Robert Spiera, MD ยท Tests: Avacopan, Placebo Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis NCT07160608Phase 278 sites๐Ÿ“ Ciudad de Buenos Aires๐Ÿ“ Ciudad de Buenos Aires๐Ÿ“ La Plata Alexion Pharmaceuticals, Inc. ยท Tests: Placebo, Tarperprumig Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty NCT07138898Phase 21 site๐Ÿ“ New York NYU Langone Health ยท Tests: Methotrexate, Sulfasalazine, Hydroxychloroquine, Leflunomide, Azathioprine Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases NCT06775912EARLY Phase 11 site๐Ÿ“ Lianyungang Nanjing Bioheng Biotech Co., Ltd. ยท Tests: RD06-05 CART Cell Injection Special Drug Use-results Survey for Long-term Use๏ผˆAvacopan๏ผ‰ NCT06758271n/a1 site๐Ÿ“ Multiple Locations Kissei Pharmaceutical Co., Ltd. ยท Tests: Avacopan Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases NCT06548607EARLY Phase 11 site๐Ÿ“ Bengbu Nanjing Bioheng Biotech Co., Ltd. ยท Tests: CD19 or CD19-BCMA CAR-T AYLo - AutoimmunitY and Loss of y NCT06696027n/a1 site๐Ÿ“ Bonn University of Bonn ยท Tests: Single nucleotide polymorphisms (SNP), 3'mRNA sequencing, Enzyme-linked immunosorbent assay (ELISA) and Legendplexโ€ฆ Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases NCT06614270NA1 site๐Ÿ“ Hangzhou Second Affiliated Hospital, Zhejiang University, School of โ€ฆ ยท Tests: Anti-CD19 IL-10/IL15 CAR-NK Obinutuzumab Beta Combined With Low-dose Glucocorticoid in New-onset ANCA-Associated Glomerulonephritis NCT07746180Phase 21 site๐Ÿ“ Beijing Chinese PLA General Hospital ยท Tests: Obinutuzumab beta, Glucocorticoids Rescue of Nephrons With ALE.F02 (RENAL-F02) NCT06047171Phase 253 sites๐Ÿ“ Prague๐Ÿ“ Prague๐Ÿ“ Aalborg Alentis Therapeutics AG ยท Tests: ALE.F02, Rituximab, GlucoCorticoid, Cyclophosphamid, Placebo An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease NCT06379646NA1 site๐Ÿ“ Shanghai China Immunotech (Beijing) Biotechnology Co., Ltd. ยท Tests: YTS109 Refractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T Cells NCT06277427NA1 site๐Ÿ“ Wuhan Lingli Dong ยท Tests: PRG-1801 ๏ผˆCAR-T against BCMA๏ผ‰ Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy NCT07150000n/a1 site๐Ÿ“ Bonn University of Bonn ยท Tests: Ex Vivo Assay A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases NCT06512883Phase 315 sites๐Ÿ“ Aurora๐Ÿ“ Cincinnati๐Ÿ“ Highland Hills AstraZeneca ยท Tests: Benralizumab Neutrophil Extracellular Traps in Different Forms of Systemic Sclerosis NCT06462768n/a1 site๐Ÿ“ Reims CHU de Reims ยท Tests: Blood sample
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy